
=== FINAL SUMMARY ===

**One-sentence overview:** The financial data from 2018 to 2019 shows significant changes, including a decrease in year-end values, a shift from profit to loss in associate shares, and notable impairments and foreign exchange losses.

1. The 'At 1 January' value increased from 64.8 in 2018 to 65.6 in 2019, marking a change of +0.8.
2. The 'At 31 December' value decreased significantly from 65.6 in 2018 to 53.7 in 2019, a change of -11.9, primarily due to impairment and foreign exchange losses.
3. The 'Share of post-tax (loss)/profit of associates' shifted from a profit of 2.3 in 2018 to a loss of (0.3) in 2019.
4. An impairment of (7.4) was recognized in 2019, with no corresponding figure in 2018.
5. 'Foreign exchange movements' resulted in a loss of (4.2) in 2019 compared to a smaller loss of (1.5) in 2018.

Answer Echoes:
- "Impairment of £7.4 million was recognised."
- "Market price per share of Prozone at 31 December 2019 was INR19."
- "Valuing the Group’s interest at £9.9 million at 31 December 2019."
- "Carrying value pre-impairment of £41.5 million at 31 December 2019."
- "Independent third-party valuations received for the investment and development properties."

=== LOGS (per-agent) ===
{'TabuSynth': {'cot': "1. Compute the change in 'At 1 January' from 2018 to "
                      '2019.\n'
                      "2. Compute the change in 'At 31 December' from 2018 to "
                      '2019.\n'
                      "3. Calculate the net effect of 'Share of post-tax "
                      "(loss)/profit of associates', 'Impairment', and "
                      "'Foreign exchange movements' for 2019.\n"
                      '4. Compare the computed changes and net effects to '
                      'identify trends or anomalies.',
               'result': "[TREND] 'At 1 January' increased from 64.8 in 2018 "
                         'to 65.6 in 2019, a change of +0.8.\n'
                         "[TREND] 'At 31 December' decreased from 65.6 in 2018 "
                         'to 53.7 in 2019, a change of -11.9.\n'
                         "[ANOMALY] 'Share of post-tax (loss)/profit of "
                         "associates' changed from a profit of 2.3 in 2018 to "
                         'a loss of (0.3) in 2019.\n'
                         "[ANOMALY] 'Impairment' was (7.4) in 2019, with no "
                         'corresponding figure in 2018.\n'
                         "[TREND] 'Foreign exchange movements' resulted in a "
                         'loss of (4.2) in 2019 compared to a smaller loss of '
                         '(1.5) in 2018.\n'
                         "[OUTLIER] The significant decrease in 'At 31 "
                         "December' from 2018 to 2019 is primarily due to the "
                         'combined negative effects of impairment and foreign '
                         'exchange movements.',
               'raw': '{\n'
                      '  "reasoning": "1. Compute the change in \'At 1 '
                      "January' from 2018 to 2019.\\n2. Compute the change in "
                      "'At 31 December' from 2018 to 2019.\\n3. Calculate the "
                      "net effect of 'Share of post-tax (loss)/profit of "
                      "associates', 'Impairment', and 'Foreign exchange "
                      "movements' for 2019.\\n4. Compare the computed changes "
                      'and net effects to identify trends or anomalies.",\n'
                      '  "bullets": [\n'
                      '    "[TREND] \'At 1 January\' increased from 64.8 in '
                      '2018 to 65.6 in 2019, a change of +0.8.",\n'
                      '    "[TREND] \'At 31 December\' decreased from 65.6 in '
                      '2018 to 53.7 in 2019, a change of -11.9.",\n'
                      '    "[ANOMALY] \'Share of post-tax (loss)/profit of '
                      "associates' changed from a profit of 2.3 in 2018 to a "
                      'loss of (0.3) in 2019.",\n'
                      '    "[ANOMALY] \'Impairment\' was (7.4) in 2019, with '
                      'no corresponding figure in 2018.",\n'
                      '    "[TREND] \'Foreign exchange movements\' resulted in '
                      'a loss of (4.2) in 2019 compared to a smaller loss of '
                      '(1.5) in 2018.",\n'
                      '    "[OUTLIER] The significant decrease in \'At 31 '
                      "December' from 2018 to 2019 is primarily due to the "
                      'combined negative effects of impairment and foreign '
                      'exchange movements."\n'
                      '  ]\n'
                      '}'},
 'Contextron': {'cot': 'The TABLE CONTEXT provides information on trends and '
                       'anomalies related to the investment in associates, '
                       'such as the impairment and foreign exchange movements. '
                       'However, it does not specify the details of the '
                       'impairment or the exact valuation figures. The CONTEXT '
                       'fills these gaps by providing specific figures and '
                       'details about the impairment and valuation of Prozone '
                       'and Empire. The CONTEXT mentions a £7.4 million '
                       'impairment and the market price per share of Prozone '
                       'at INR19, valuing the Group’s interest at £9.9 '
                       'million. These details are crucial to fully answering '
                       'the questions, as they provide the specific financial '
                       'impacts and valuations that are not present in the '
                       'TABLE CONTEXT.',
                'result': '- "Impairment of £7.4 million was recognised."\n'
                          '- "Market price per share of Prozone at 31 December '
                          '2019 was INR19."\n'
                          '- "Valuing the Group’s interest at £9.9 million at '
                          '31 December 2019."\n'
                          '- "Carrying value pre-impairment of £41.5 million '
                          'at 31 December 2019."\n'
                          '- "Independent third-party valuations received for '
                          'the investment and development properties."',
                'raw': 'The TABLE CONTEXT provides information on trends and '
                       'anomalies related to the investment in associates, '
                       'such as the impairment and foreign exchange movements. '
                       'However, it does not specify the details of the '
                       'impairment or the exact valuation figures. The CONTEXT '
                       'fills these gaps by providing specific figures and '
                       'details about the impairment and valuation of Prozone '
                       'and Empire. The CONTEXT mentions a £7.4 million '
                       'impairment and the market price per share of Prozone '
                       'at INR19, valuing the Group’s interest at £9.9 '
                       'million. These details are crucial to fully answering '
                       'the questions, as they provide the specific financial '
                       'impacts and valuations that are not present in the '
                       'TABLE CONTEXT.\n'
                       '\n'
                       '- "Impairment of £7.4 million was recognised."\n'
                       '- "Market price per share of Prozone at 31 December '
                       '2019 was INR19."\n'
                       '- "Valuing the Group’s interest at £9.9 million at 31 '
                       'December 2019."\n'
                       '- "Carrying value pre-impairment of £41.5 million at '
                       '31 December 2019."\n'
                       '- "Independent third-party valuations received for the '
                       'investment and development properties."'},
 'SummaCraft': {'cot': '(omitted)',
                'result': '**One-sentence overview:** The financial data from '
                          '2018 to 2019 shows significant changes, including a '
                          'decrease in year-end values, a shift from profit to '
                          'loss in associate shares, and notable impairments '
                          'and foreign exchange losses.\n'
                          '\n'
                          "1. The 'At 1 January' value increased from 64.8 in "
                          '2018 to 65.6 in 2019, marking a change of +0.8.\n'
                          "2. The 'At 31 December' value decreased "
                          'significantly from 65.6 in 2018 to 53.7 in 2019, a '
                          'change of -11.9, primarily due to impairment and '
                          'foreign exchange losses.\n'
                          "3. The 'Share of post-tax (loss)/profit of "
                          "associates' shifted from a profit of 2.3 in 2018 to "
                          'a loss of (0.3) in 2019.\n'
                          '4. An impairment of (7.4) was recognized in 2019, '
                          'with no corresponding figure in 2018.\n'
                          "5. 'Foreign exchange movements' resulted in a loss "
                          'of (4.2) in 2019 compared to a smaller loss of '
                          '(1.5) in 2018.\n'
                          '\n'
                          'Answer Echoes:\n'
                          '- "Impairment of £7.4 million was recognised."\n'
                          '- "Market price per share of Prozone at 31 December '
                          '2019 was INR19."\n'
                          '- "Valuing the Group’s interest at £9.9 million at '
                          '31 December 2019."\n'
                          '- "Carrying value pre-impairment of £41.5 million '
                          'at 31 December 2019."\n'
                          '- "Independent third-party valuations received for '
                          'the investment and development properties."',
                'raw': '**One-sentence overview:** The financial data from '
                       '2018 to 2019 shows significant changes, including a '
                       'decrease in year-end values, a shift from profit to '
                       'loss in associate shares, and notable impairments and '
                       'foreign exchange losses.\n'
                       '\n'
                       "1. The 'At 1 January' value increased from 64.8 in "
                       '2018 to 65.6 in 2019, marking a change of +0.8.\n'
                       "2. The 'At 31 December' value decreased significantly "
                       'from 65.6 in 2018 to 53.7 in 2019, a change of -11.9, '
                       'primarily due to impairment and foreign exchange '
                       'losses.\n'
                       "3. The 'Share of post-tax (loss)/profit of associates' "
                       'shifted from a profit of 2.3 in 2018 to a loss of '
                       '(0.3) in 2019.\n'
                       '4. An impairment of (7.4) was recognized in 2019, with '
                       'no corresponding figure in 2018.\n'
                       "5. 'Foreign exchange movements' resulted in a loss of "
                       '(4.2) in 2019 compared to a smaller loss of (1.5) in '
                       '2018.'}}
